Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The ...

Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is ...

Following FDA approval late last year for the treatment of HER2-positive biliary tract cancer (BTC), this milestone represents a step forward in targeted cancer therapy. “The market availability of a ...

Tarlatamab-dlle significantly improves overall survival in SCLC compared to standard chemotherapy, as demonstrated in the phase 3 DeLLphi-304 trial. The bispecific T-cell engager targets DLL3 on ...

In addition, those with known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC, were also not eligible for participation. The primary end point of the study was OS, and ...

HistoSeg is an Encoder-Decoder DCNN which utilizes the novel Quick Attention Modules and Multi Loss function to generate segmentation masks from histopathological images with greater accuracy. This ...

MILWAUKEE (WKOW) — A cat is recovering after being trapped in an air duct for three weeks. Our ABC affiliate, WISN 12 News in Milwaukee watched the rescue unfold after the distressed owner called for ...

Primary biliary cholangitis (PBC) is an autoimmune disorder that leads to the destruction of bile ducts within the liver. As more bile ducts become lost and damaged, bile acids build up within the ...

Tariffs on imports could increase costs and worsen shortages of pharmaceuticals and medical supplies in the US healthcare system. The US heavily relies on pharmaceutical imports, with China being ...